Evidence map›Paper›PMID 41752203›Full record

ArticleInternational journal of molecular sciences2026

Sankar Sekar, Sutha Sadhasivam, Saravanan Sekar, Youngmin Lee, Sekar Vaithilingam, Nandhakumar Srinivasan, Elangovan Krishnan, Sejoon Lee, Balaji Murugan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sankar SekarDivision of System Semiconductor, Dongguk University-Seoul, Seoul 04620, Republic of Korea.ORCID 0000-0001-9554-2328
Sutha SadhasivamDepartment of Chemistry, CMS College of Engineering, Ernapuram, Namakkal 637003, Tamil Nadu, India.
Saravanan SekarDepartment of Mechanical Engineering, K. Ramakrishnan College of Technology, Trichy 621112, Tamil Nadu, India.
Youngmin LeeDivision of System Semiconductor, Dongguk University-Seoul, Seoul 04620, Republic of Korea.ORCID 0000-0002-8685-3033
Sekar VaithilingamSchool of Engineering and Technology, Dhanalakshmi Srinivasan University, Trichy 621112, Tamil Nadu, India.
Nandhakumar SrinivasanSchool of Engineering and Technology, Dhanalakshmi Srinivasan University, Perambalur 621212, Tamil Nadu, India.
Elangovan KrishnanSchool of Engineering and Technology, Dhanalakshmi Srinivasan University, Perambalur 621212, Tamil Nadu, India.
Sejoon LeeDivision of System Semiconductor, Dongguk University-Seoul, Seoul 04620, Republic of Korea.ORCID 0000-0002-4548-7436
Balaji MuruganDepartment of Electrical & Computer Engineering, National University of Singapore, Singapore 117608, Singapore.ORCID 0000-0002-6699-6360

Funding

National Research Foundation (NRF) of Korea RS-2023-NR076644
6 · The paper itself

Abstract

During recent decades, bone cancer-related diseases have remained hard to treat because of poor diagnosis, systemic toxicity, and restricted conventional treatments. Hence, the fabrication of functionalised nanoparticles offers a promising alternative by limiting side effects and improving therapeutic outcomes. In this study, zinc-substituted hydroxyapatite (Zn-HA) nanoparticles were fabricated from biogenic tuna fish bone waste via a thermal decomposition method and subsequently functionalised with

Indexed as

Antineoplastic AgentsAntioxidantsCatharanthusDurapatiteNanocompositesPlant ExtractsZincAnimalsAnti-Bacterial AgentsCell Line, TumorEscherichia coliHumansStaphylococcus aureusAnti-Bacterial AgentsAntineoplastic AgentsAntioxidantsDurapatitePlant ExtractsZincanticancer activityCatharanthus roseushydroxyapatitetuna fish bone

Identifiers

PMID41752203
PMCPMC12941289

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.